Biozipcode, Inc., which is working to develop therapeutics aimed at curing diabetes through an industry–academia collaboration with Shiga University of Medical Science, will exhibit at BioJapan2022, held at PACIFICO Yokohama from Wednesday, October 12 to Friday, October 14, 2022, with support from the Union of Kansai Governments and Shiga Prefecture.

BioJapan2022 offers the following features:

  • Asia’s largest business partnering event in the life sciences sector
  • An exhibition covering drug discovery, biotechnology, regenerative medicine, and healthcare that connects participants with major companies, universities, research institutions, and investors from Japan and overseas, providing opportunities to share information with domestic and international audiences
  • A partnering system that allows participants to schedule meetings in advance and access numerous meeting opportunities, including online meetings

Through this event, Biozipcode, Inc. will exchange information relevant to its development of therapeutics aimed at curing difficult-to-treat diseases, including diabetes, cancer, and autoimmune disorders, and explore collaborations with promising potential partners.

Through the Union of Kansai Governments, Biozipcode, Inc. was selected for Shiga Prefecture’s single company slot and provided with a paid account for the partnering system. Through this initiative, we aim to meet with pharmaceutical companies, health food manufacturers, and research institutions interested in diabetes treatment and regenerative medicine, and to accelerate product development and research on both sides.

For inquiries regarding this announcement, please contact us using the details below.

Biozipcode, Inc.
TEL: 050-5534-7865
E-mail: info@biozipcode.com